Loading…
Loading…
EQUITY / NASDAQ · XNCM
Acurx Pharmaceuticals Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗1.26 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 1.26 USD · Volume 130,441
22 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Net income | -2,254,173 USD | -2,246,279 USD | — |
| Operating profit | -2,307,228 USD | -2,269,683 USD | — |
| Total assets | 10,984,777 USD | — | — |
| Total equity | 8,152,031 USD | 3,566,331 USD | +128.58% |
| Total liabilities | 2,832,746 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -2,254,173 USD | -3,935,155 USD | -1,680,982 USD | — | -7,966,538 USD | -1,992,790 USD | -6,388,262 USD | -2,246,279 USD |
| Operating profitIncome statement | -2,307,228 USD | -4,023,219 USD | — | — | -8,091,983 USD | -2,028,701 USD | -6,474,867 USD | -2,269,683 USD |
| Total assetsBalance sheet | 10,984,777 USD | — | — | 7,689,535 USD | 7,689,535 USD | 6,105,211 USD | — | — |
| Total equityBalance sheet | 8,152,031 USD | — | 7,013,143 USD | 5,268,592 USD | 5,268,592 USD | 3,637,036 USD | — | 3,566,331 USD |
| Total liabilitiesBalance sheet | 2,832,746 USD | — | — | 2,420,943 USD | 2,420,943 USD | 2,468,175 USD | — | — |
| Financing cash flowCash flow statement | — | 6,217,771 USD | — | — | 10,637,169 USD | — | 7,803,131 USD | — |
| Operating cash flowCash flow statement | — | -3,117,485 USD | — | — | -6,787,782 USD | — | -5,603,042 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/12/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.